Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Leukemia

  Free Subscription


30.09.2019

1 Blood
4 Bone Marrow Transplant
2 Cancer
1 Int J Hematol
6 Leuk Lymphoma
3 Leuk Res
1 Oncol Rep


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Blood

  1. RUCKER FG, Agrawal M, Corbacioglu A, Weber D, et al
    Measurable Residual Disease Monitoring in Acute Myeloid Leukemia with t(8;21)(q22;q22.1): Results of the AML Study Group.
    Blood. 2019 Sep 25. pii: blood.2019001425. doi: 10.1182/blood.2019001425.
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  2. DEBUREAUX PE, Labopin M, Mamez AC, Lapusan S, et al
    Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia.
    Bone Marrow Transplant. 2019 Sep 25. pii: 10.1038/s41409-019-0690.
    PubMed     Text format     Abstract available

  3. BASQUIERA AL, Berro M, Yantorno S, Castro M, et al
    Haploidentical transplant in adult patients with acute lymphoblastic leukemia in Argentina: a comparison with matched related and unrelated donors.
    Bone Marrow Transplant. 2019 Sep 24. pii: 10.1038/s41409-019-0687.
    PubMed     Text format     Abstract available

  4. CASTAGNOLA E, Bagnasco F, Menoni S, Muraca M, et al
    Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GIT
    Bone Marrow Transplant. 2018 Mar 21. pii: 10.1038/s41409-018-0160.
    PubMed     Text format    

  5. GASSAS A, Sivaprakasam P, Cummins M, Breslin P, et al
    High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0157.
    PubMed     Text format     Abstract available


    Cancer

  6. NAQVI K, Jabbour E, Skinner J, Anderson K, et al
    Long-term follow-up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia.
    Cancer. 2019 Sep 25. doi: 10.1002/cncr.32504.
    PubMed     Text format     Abstract available

  7. JIM HSL, Hyland KA, Nelson AM, Pinilla-Ibarz J, et al
    Internet-assisted cognitive behavioral intervention for targeted therapy-related fatigue in chronic myeloid leukemia: Results from a pilot randomized trial.
    Cancer. 2019 Sep 25. doi: 10.1002/cncr.32521.
    PubMed     Text format     Abstract available


    Int J Hematol

  8. MA Y, Leng Q, Zhao Y, Wang E, et al
    Promyelocyte-like blasts in B-lymphoblastic leukemia of a 67-year-old male patient.
    Int J Hematol. 2019 Sep 25. pii: 10.1007/s12185-019-02732.
    PubMed     Text format    


    Leuk Lymphoma

  9. BHATNAGAR B, Zhao Q, Mims AS, Vasu S, et al
    Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study.
    Leuk Lymphoma. 2019 Sep 23:1-10. doi: 10.1080/10428194.2019.1665664.
    PubMed     Text format     Abstract available

  10. ZHANG H, Ying H, Wang X
    Methyltransferase DNMT3B in leukemia.
    Leuk Lymphoma. 2019 Sep 24:1-11. doi: 10.1080/10428194.2019.1666377.
    PubMed     Text format     Abstract available

  11. MULLIGAN SP, Shumack S, Guminski A
    Chronic lymphocytic leukemia, skin and other second cancers.
    Leuk Lymphoma. 2019 Sep 24:1-3. doi: 10.1080/10428194.2019.1665669.
    PubMed     Text format    

  12. DENG R, Gibiansky L, Lu T, Li X, et al
    Exposure-response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study.
    Leuk Lymphoma. 2019 Sep 24:1-10. doi: 10.1080/10428194.2019.1657575.
    PubMed     Text format     Abstract available

  13. ANDREWS C, Lipton J
    The role of ponatinib in chronic myeloid leukemia in the era of treatment free remission.
    Leuk Lymphoma. 2019 Sep 26:1-3. doi: 10.1080/10428194.2019.1665667.
    PubMed     Text format    

  14. GURBUXANI S
    Lymphoblastic leukemia following MDS or MDS/MPN: clinical evidence for stem cell origins of these disorders.
    Leuk Lymphoma. 2019 Sep 26:1-2. doi: 10.1080/10428194.2019.1666382.
    PubMed     Text format    


    Leuk Res

  15. MARCOLIN R, Guolo F, Minetto P, Clavio M, et al
    A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia.
    Leuk Res. 2019;86:106223.
    PubMed     Text format     Abstract available

  16. DEANGELO DJ, Walker AR, Schlenk RF, Sierra J, et al
    Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia.
    Leuk Res. 2019;85:106197.
    PubMed     Text format     Abstract available

  17. LIU M, Liao H, Chen Y, Lin Z, et al
    Treatment of human T-cell acute lymphoblastic leukemia cells with CFTR inhibitor CFTRinh-172.
    Leuk Res. 2019;86:106225.
    PubMed     Text format     Abstract available


    Oncol Rep

  18. RYU MJ, Han J, Kim SJ, Lee MJ, et al
    PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis.
    Oncol Rep. 2019 Sep 12. doi: 10.3892/or.2019.7308.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: